Publications

Found 5 results
Filters: Author is S. Yan  [Clear All Filters]
2012
S. Yan, Li, Y. Z., Zhu, J. W., Liu, C. L., Wang, P., and Liu, Y. L., Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and meta-analysis, vol. 11, pp. 3998-4007, 2012.
Alison MR and Sarraf CE (1992). Apoptosis: a gene-directed programme of cell death. J. R. Coll. Physicians Lond. 26: 25-35. PMid:1315390   Boatright KM and Salvesen GS (2003). Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15: 725-731. http://dx.doi.org/10.1016/j.ceb.2003.10.009 PMid:14644197   Doonan F and Cotter TG (2008). Morphological assessment of apoptosis. Methods 44: 200-204. http://dx.doi.org/10.1016/j.ymeth.2007.11.006 PMid:18314050   Frank B, Hemminki K, Wappenschmidt B, Meindl A, et al. (2006). Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27: 606-609. http://dx.doi.org/10.1093/carcin/bgi248 PMid:16251207   Gaudet MM, Milne RL, Cox A, Camp NJ, et al. (2009). Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev. 18: 1610-1616. http://dx.doi.org/10.1158/1055-9965.EPI-08-0745 PMid:19423537 PMCid:2737177   Ghavami S, Hashemi M, Ande SR, Yeganeh B, et al. (2009). Apoptosis and cancer: mutations within caspase genes. J. Med. Genet. 46: 497-510. http://dx.doi.org/10.1136/jmg.2009.066944 PMid:19505876   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919   Hosgood HD, III, Baris D, Zhang Y, Zhu Y, et al. (2008). Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol. Oncol. 26: 148-151. http://dx.doi.org/10.1002/hon.852 PMid:18381704 PMCid:2586415   Kim MS, Oh JE, Min CK, Lee S, et al. (2009). Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas. Pathology 41: 484-487. http://dx.doi.org/10.1080/00313020903041143 PMid:19900088   Kumar S (2004). Measurement of caspase activity in cells undergoing apoptosis. Methods Mol. Biol. 282: 19-30. PMid:15105554   Lan Q, Zheng T, Chanock S, Zhang Y, et al. (2007). Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28: 823-827. http://dx.doi.org/10.1093/carcin/bgl196 PMid:17071630   Li C, Zhao H, Hu Z, Liu Z, et al. (2008). Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum. Mutat. 29: 1443-1451. http://dx.doi.org/10.1002/humu.20803 PMid:18563783 PMCid:2937220   MacPherson G, Healey CS, Teare MD, Balasubramanian SP, et al. (2004). Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer Inst. 96: 1866-1869. http://dx.doi.org/10.1093/jnci/dji001 PMid:15601643   Nicholson DW (1996). ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol. 14: 297-301. http://dx.doi.org/10.1038/nbt0396-297 PMid:9630889   Nicholson DW and Thornberry NA (1997). Caspases: killer proteases. Trends Biochem. Sci. 22: 299-306. http://dx.doi.org/10.1016/S0968-0004(97)01085-2   Niles AL, Moravec RA and Riss TL (2008). Caspase activity assays. Methods Mol. Biol. 414: 137-150. PMid:18175817   Oh JE, Kim MS, Ahn CH, Kim SS, et al. (2010). Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas. Pathology 42: 73-76. http://dx.doi.org/10.3109/00313020903434371 PMid:20025484   Park WS, Lee JH, Shin MS, Park JY, et al. (2002). Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21: 2919-2925. http://dx.doi.org/10.1038/sj.onc.1205394 PMid:11973654   Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. http://dx.doi.org/10.1001/jama.295.6.676 PMid:16467236   Rupinder SK, Gurpreet AK and Manjeet S (2007). Cell suicide and caspases. Vascul. Pharmacol. 46: 383-393. http://dx.doi.org/10.1016/j.vph.2007.01.006 PMid:17382599   Shin MS, Kim HS, Kang CS, Park WS, et al. (2002). Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99: 4094-4099. http://dx.doi.org/10.1182/blood.V99.11.4094 PMid:12010812   Ulybina YM, Kuligina ES, Mitiushkina NV, Rozanov ME, et al. (2009). Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett. 278: 183-191. http://dx.doi.org/10.1016/j.canlet.2009.01.012 PMid:19203830   von Elm E, Altman DG, Egger M, Pocock SJ, et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18: 800-804. http://dx.doi.org/10.1097/EDE.0b013e3181577654 PMid:18049194   Wang J, Chun HJ, Wong W, Spencer DM, et al. (2001). Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 98: 13884-13888. http://dx.doi.org/10.1073/pnas.241358198 PMid:11717445 PMCid:61136   Ye YF (2004). Polymorphisms of Caspase-8, -10 Genes and Their Relationship with Pathogenesis of Non-Hodgkin lymphoma. Master's thesis, Zhejiang University School of Medicine, Zhejiang.   Zhang L, Liu JL, Zhang YJ and Wang H (2011). Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin. Exp. Rheumatol. 29: 285-292. PMid:21418777   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093